Related Experiment Video
Updated: Jul 17, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Lipid research. Possible new way to lower cholesterol
Abstract:
Clinicians may soon be able to mount a multipronged attack against cholesterol, the artery-clogging lipid whose buildup in the body is a major contributor to heart attacks and other cardiovascular diseases. In work reported on page 1524, a team has pinpointed a biological master switch in mice that controls three pathways that work together to both rid the body of excess cholesterol and prevent its absorption from the intestine. The work suggests a new mechanism for reducing cholesterol, for example, with drugs that turn up the activity of the master switch, a protein known as the retinoid X receptor.
Insights
Researchers identified a master switch, the retinoid X receptor, controlling cholesterol levels in mice. This discovery may lead to new drugs for reducing cholesterol and preventing heart disease.
Area of Science:
- Molecular biology
- Cardiovascular research
- Lipid metabolism
Background:
- High cholesterol is a major risk factor for cardiovascular diseases, including heart attacks.
- Existing treatments focus on managing cholesterol levels, but new strategies are needed.
- Understanding the regulatory mechanisms of cholesterol homeostasis is crucial for developing novel therapies.
Discussion:
- A biological master switch, the retinoid X receptor (RXR), has been identified in mice.
- RXR controls three key pathways involved in cholesterol regulation.
- These pathways collectively manage cholesterol elimination and absorption in the intestine.
Key Insights:
- Targeting RXR activity offers a potential new therapeutic approach for cholesterol reduction.
- Activating RXR could simultaneously enhance cholesterol excretion and decrease intestinal absorption.
- This finding provides a novel mechanism for combating hypercholesterolemia.
Outlook:
- Further research is needed to validate these findings in humans.
- Development of drugs that modulate RXR activity could offer a multipronged strategy against high cholesterol.
- This approach holds promise for reducing the burden of cardiovascular disease.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Dipeptidyl Peptidase 4 Inhibitors
Atherosclerosis III: Management

